May 22-24, 2023 | Renaissance Hotel, Carmel, Indiana
Get a chance to meet and discuss topics under this year’s theme of “statistical excellence in drug development” with leaders from industry and academia.
Be sure to come meet our team!
Short Course
Bruno Boulanger and Brad Carlin, PharmaLex
Bayesian Approaches for Accelerating Drug and Medical Device Approvals
Speakers
Lira Pi, PharmaLex
Nonparametric screenings and penalized regression on time-to-event outcomes from case-cohort designs
Sessions chaired by our team
Jennifer Schroeder, Associate Director Statistics, PharmaLex
BIOMARKERS/PRE-CLINICAL/DISCOVERY: Statistical Approaches for Biomarker and Diagnostics; Carmel 1
Tuesday May 23, 2023 | 8:30 AM – 11:30 AM
Brad Carlin, Senior Advisor, Data Science and Statistics, PharmaLex
CLINICAL: Modern Bayesian Approaches to Using Historical, Auxillary, and Real World Data in Drug Development; Carmel 3&4
Tuesday May 23, 2023 | 1:30 PM – 4:30 PM
Lin Li, US Head of Statistics and Data Science, PharmaLex; Hui-Rong Qian, Eli Lilly and Company
BIOMARKERS/PRE-CLINICAL/DISCOVERY: Experimental design and data analysis in discovery and developmental research; Carmel 1
“Nonparametric screenings and penalized regression on time-to-event outcomes from case-cohort designs”, Lira Pi, PharmaLex
Tuesday May 23, 2023 | 1:30 PM – 4:30 PM
Erin Wagner, Director, Biomarker Analytics, PharmaLex
BIOMARKERS/PRE-CLINICAL/DISCOVERY; Statistical Approaches for Discovery and Preclinical Research; Carmel 1
Wednesday May 24, 2023 | 8:30 AM – 11:30 AM
Panelists
Lin Li, US Head of Statistics and Data Science, PharmaLex
